China Issues Biosimilar Guidelines Draft
After years of waiting, Chinese biosimilar makers will soon have a set of guidelines to follow.
China Issues Biosimilar Guidelines Draft Read More »
After years of waiting, Chinese biosimilar makers will soon have a set of guidelines to follow.
China Issues Biosimilar Guidelines Draft Read More »
While many see Hong Kong as ideally positioned to become a global hub for digital currencies and internet finance, the road forward seems far from clear.
Bitcoin in Hong Kong Read More »
Cheap oil has helped Indonesia eliminate punishing subsidies and while the move is likely to bump inflation up, it will also free up a about US$21 billion that the government can now spend on infrastructure or social programs.
Cheap oil helps Indonesia Read More »
Environment, productivity and work hours are all big issues
Asian cities need sustainability Read More »
When Indonesia’s Investment Coordinating Board (BKPM) rejected some 6,541 foreign investment permits last month, it underscored a problem Indonesia has been facing for a couple of years. Investors are looking at the country.
Indonesia’s FDI troubles Read More »
It is no surprise that the life science sector including pharmaceutical, medical devices etc. is one of the hottest investment destinations.
Australia’s largest life science fund Read More »
China is not a powerhouse of innovation, yet, but it is certainly trying to pay its way into that particular status.
R&D spend driving China pharma co’s Read More »
This year’s BOAO Forum for Asia (BFA) has a theme of Asia’s New Future: New Dynamics, New Vision.
2016 BOAO Forum for Asia Read More »
It has been a long time coming, but the first dengue vaccine should hit the market next year in Mexico and, with any luck, in about 20 markets over the next couple of years.
A dengue vaccine… finally Read More »
There are few issues with just two sides or a clear right and wrong.
This is a recurrent theme for us and one that Sergio Held makes quite clear in a recent story for Ozy that considers the difficulty that Colombia is facing in cutting down on drug production.
Dealing with drugs: Colombia’s dilemma Read More »